{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:03:47Z","timestamp":1784966627701,"version":"3.55.0"},"reference-count":35,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatitis"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1097\/der.0000000000000845","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T06:50:28Z","timestamp":1644994228000},"page":"200-206","source":"Crossref","is-referenced-by-count":34,"title":["Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey"],"prefix":"10.1177","volume":"33","author":[{"given":"Aaron M.","family":"Drucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Flohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob P.","family":"Thyssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kabashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bissonnette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ncoza C.","family":"Dlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Micieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Nosbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"issue":"4","key":"bib1-20220520","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jaad.2017.06.042","article-title":"When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council","volume":"77","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"bib2-20220520","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bjd.15928","article-title":"Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement","volume":"178","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"bib3-20220520","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaad.2015.10.043","article-title":"Patient burden of moderate to severe atopic dermatitis (AD): insights from a phase 2b clinical trial of dupilumab in adults","volume":"74","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"bib4-20220520","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jamadermatol.2020.0796","article-title":"Systemic immunomodulatory treatments for patients with atopic dermatitis: a systematic review and network meta-analysis","volume":"156","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"9","key":"bib5-20220520","first-page":"CD013206","article-title":"Systemic treatments for eczema: a network meta-analysis","volume":"9","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"bib6-20220520","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jamadermatol.2020.2940","article-title":"Inclusion of older adults in randomized clinical trials for systemic medications for atopic dermatitis: a systematic review","volume":"156","year":"2020","journal-title":"JAMA Dermatol"},{"key":"bib7-20220520","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1203475421993770","article-title":"Safety of systemic medications among older adults with psoriasis and atopic dermatitis: a systematic review of observational studies","volume":"25","year":"2021","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"bib8-20220520","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","year":"2005","journal-title":"Int J Soc Res Methodol Theory Pract"},{"issue":"7","key":"bib9-20220520","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"bib10-20220520","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1440-0960.1994.tb00895.x","article-title":"Cyclosporin treatment of atopic dermatitis: five case studies and literature review","volume":"35","year":"1994","journal-title":"Australas J Dermatol"},{"issue":"10","key":"bib11-20220520","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2340\/00015555-3201","article-title":"Two cancer patients receiving dupilumab for treatment of atopic dermatitis","volume":"99","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"bib12-20220520","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/pde.13115","article-title":"Low-dose cyclosporine A in the treatment of severe atopic dermatitis complicated by chronic hepatitis C virus infection","volume":"34","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"bib13-20220520","doi-asserted-by":"crossref","first-page":"100848","DOI":"10.1016\/j.ajoc.2020.100848","article-title":"Corneal ulceration associated with dupilumab use in a patient with atopic dermatitis","volume":"19","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"4","key":"bib14-20220520","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/DER.0000000000000501","article-title":"Successful use of dupilumab for recalcitrant atopic dermatitis in an HIV patient","volume":"30","year":"2019","journal-title":"Dermatitis"},{"issue":"6","key":"bib15-20220520","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/ced.14278","article-title":"Safety and efficacy of dupilumab in a patient with severe atopic dermatitis and HIV infection, with 15 months of follow-up","volume":"45","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"bib16-20220520","first-page":"131","article-title":"Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumab","volume":"106","year":"2020","journal-title":"Cutis"},{"issue":"6","key":"bib17-20220520","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/bjd.18222","article-title":"Use of dupilumab in patients who are HIV-positive: report of four cases","volume":"181","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1","key":"bib18-20220520","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2340\/00015555-0327","article-title":"Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B","volume":"88","year":"2008","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"bib19-20220520","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.2008.08835.x","article-title":"Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"160","year":"2009","journal-title":"Br J Dermatol"},{"issue":"2","key":"bib20-20220520","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1097\/DER.0000000000000560","article-title":"Treatment of atopic dermatitis with dupilumab in a renal transplant patient","volume":"31","year":"2020","journal-title":"Dermatitis"},{"issue":"7","key":"bib21-20220520","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/09546634.2019.1711010","article-title":"Punctal stenosis associated with dupilumab therapy for atopic dermatitis","volume":"32","year":"2021","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"bib22-20220520","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jdcr.2019.05.007","article-title":"Dupilumab in patients with chronic hepatitis B on concomitant entecavir","volume":"5","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"6","key":"bib23-20220520","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jaad.2017.01.030","article-title":"Assessment of major comorbidities in adults with atopic dermatitis using the Charlson Comorbidity Index","volume":"76","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"bib24-20220520","first-page":"e13498","article-title":"Long-term safety of combined biological therapy in a patient affected by arthropathic psoriasis and atopic dermatitis","volume":"33","year":"2020","journal-title":"Dermatol Ther"},{"issue":"5","key":"bib25-20220520","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jaad.2020.05.128","article-title":"Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry","volume":"83","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"bib26-20220520","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/09546634.2019.1662881","article-title":"Outcomes of prolonged and low-dose ciclosporin in an Asian population","volume":"32","year":"2021","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"bib27-20220520","first-page":"131","article-title":"Hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis in a toddler with food hypersensitivity","volume":"18","year":"2008","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"6","key":"bib28-20220520","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/jdv.16078","article-title":"Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany","volume":"34","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"bib29-20220520","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/ddg.14074","article-title":"Effectiveness and safety of dupilumab for atopic dermatitis in a liver transplant recipient: a case report","volume":"18","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"bib30-20220520","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2230.1989.tb00943.x","article-title":"Resolution of atopic dermatitis in a patient treated with cyclosporin","volume":"14","year":"1989","journal-title":"Clin Exp Dermatol"},{"issue":"11","key":"bib31-20220520","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jdcr.2019.08.023","article-title":"The utility of dupilumab for use in the pediatric population","volume":"5","year":"2019","journal-title":"JAAD Case Reports"},{"issue":"1","key":"bib32-20220520","first-page":"73","article-title":"Natural killer cell deficiency associated with Hodgkin's lymphoma: a case report","volume":"101","year":"2002","journal-title":"J Formos Med Assoc"},{"issue":"6","key":"bib33-20220520","first-page":"e14159","article-title":"Use of dupilumab in a patient with atopic dermatitis, severe asthma, and HIV infection","volume":"33","year":"2020","journal-title":"Dermatol Ther"},{"issue":"6","key":"bib34-20220520","first-page":"e14271","article-title":"Safe and effective treatment of atopic dermatitis using dupilumab over 23 months in a patient with HIV","volume":"33","year":"2020","journal-title":"Dermatol Ther"},{"issue":"1","key":"bib35-20220520","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaad.2018.06.056","article-title":"Psoriasis: which therapy for which patient: focus on special populations and chronic infections","volume":"80","year":"2019","journal-title":"J Am Acad Dermatol"}],"container-title":["Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DER.0000000000000845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:06:18Z","timestamp":1777399578000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000845","relation":{},"ISSN":["2162-5220","1710-3568"],"issn-type":[{"value":"2162-5220","type":"electronic"},{"value":"1710-3568","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,15]]}}}